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Abstract The field of pharmaceutical health care is becoming increasingly 
established. Modernly, pharmacists learn more from patients about their 
prescriptions and other very personal, sensitive information. However, 
having access to an ever-increasing amount of sensitive, personal 
information raises serious issues pertaining to patient secrets and 
confidentiality. The term professional secrecy (hereinafter confidentiality) 
as well as any other form of discretion connected with a professional 
activity is construed broadly. However, the precise scope of confidentiality 
is not strictly defined in legislation. Obligation of professional secrecy has 
been diminished partly due to the general progress in a society and the 
progress of medical professions. The development of the protection of 
human rights is a continuous process. 
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1 Introduction  
 
The goal of this article is to explore medical-legal issues involving patient confidentiality 
in the field of pharmaceutical health care, as such issues are becoming increasingly 
important and yet are often overlooked in the general field of health services. Namely, 
there is always a relationship between the physician and the patient, and therapies, ie 
medication treatment, are in the second plan. This is also the case today from the point of 
view of the Law of the Republic of Serbia, because a public debate on new legislation is 
taking place. There is a question of protecting the rights of individuals as users of 
medicines in this context and, in particular, the right to privacy and confidentiality of 
their data used in connection with their pharmaceutical health care. This article also 
explores these issues through a discussion of some of the foreign sources and relevant 
case law that plays an important role in the national court practice. The first part of this 
article discusses valid regulations; the second part of the article focuses on professional 
practices in the field of pharmaceutical health care services and the requirements for 
respecting patient/consumers’  rights of confidentiality; and, the third part of he article 
explores controversial cases in judicial practice and the protection of the right to 
privacy/confidentiality. It is concluded that the area of handling and use of medicines is 
accompanied by numerous data and information about patients - consumers. These data 
are very sensitive and should be recognized as having the meaning of medical 
documentation. The privacy and trustworthiness of users includes both advices from 
pharmacists when issuing medicines. These tips today have the character of wider 
services according the standards of best professional practice, diferrent than it was in the 
past. The protection of the rights of a pharmaceutical patient is in this manner gaining 
more importance. 
 
Generally, the necessity of keeping a professional “secret” (confidentiality)  came about 
due to the nature of certain professions that render services or assistance in highly 
personal matters where confidentiality is expected (physicians, lawyers, psychologists, 
priests, social workers, etc.). Indeed, the physician-patient privilege, or confidentiality of 
information between physician and patient, is one of the oldest forms of professional 
secrets. Privacy and confidentiality in the medical profession is very important from both 
an ethical and legal standpoint. 
 
It is a well-known fact found in medical literature that a physician's obligation of 
maintaining the confidentiality of patient information has been considered holy since 
Hippocrates: … “and whatsoever I shall see or hear in the course of my profession, as 
well as outside my profession in my intercourse with men, if it be what should not be 
published abroad, I will never divulge, holding such things to be holy secrets” 
(Beauchamp, Childress, 2001: 113).  
 
Maintaining confidentiality (i.e., keeping a secret) had long been exclusively a moral 
obligation. Transforming the previously moral obligation into a legal one came much 
later, e.g. a lawyers’ obligation (Radišić, 2008: 155). In prior times, private information 
about individual sphere kept secret for reasons of morality or courtesy and not under 
compulsion of the law. Keeping secrets (maintaining confidentiality of information) was 
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expected in everyday life and was common. Today, unlike that period, the privacy rights 
of people and their personal data is part of the general protection of human rights. With 
further advancements in the field of electronic data transfer the patient/consumer will be 
able to check his/her personal health status on-line, electronically. These developments 
have privacy/confidentiality implications.  
 
When we examine the pharmaceutical profession, and pharmacies in particular, it is 
necessary to consider how the pharmacist’s services to his or her customers (i.e. 
medication consumers) impacts issues pertaining to trust, privacy and confidentiality. 
The pharmacist's essential activity  is no longer the production of medicines, nor sales, 
but primarily the delivery of the medicines. Therefore, the pharmacist's focus is very often 
on the advice relating to the patient's needs, and also on confidentiality and proper 
management of the consumer/patient's information (Fasset, 2007: 1265). When 
dispensing medicines, the pharmacist has the responsibility to make decisions that are of 
a legal character. The pharmacist's dispensation of medicines is essentially an 
independent analysis and a process for which the pharmacist carries his or her own 
professional and legal responsibility, personally and unmodified, with due respect for the 
physician and the patient (Dukes, Mildred, Swartz, 1999: 381–382). 
 
2 Legal framework 
 
Establishing a legal, regulatory framework in the field of protection of privacy interests 
has a long tradition. Numerous international and local legal instruments emphasize as 
their central tenets the notions of both the protection of private life and the right to be 
informed. The European Convention on Human Rights and Fundamental Freedoms1 
stipulates that every individual has the right to the full respect of their own private life. 
This basic principle embodies the idea that governments will not interfere with this right 
unless prescribed differently by law or unless some degree of interference is necessary in 
order to protect the health, morals and rights of other people. Promoting this right to 
privacy in turn justifies the existence of professional confidentiality. The protection of 
medical data falls under the scope of Article 8 of the European Convention on Human 
Rights (ECHR). 
 
The European Convention on Human Rights and Biomedicine2 is a crucial document that 
helps enshrine the principle of privacy of medical information. In particular, this law 
provides that everyone has the right to the full respect of their private life, including 
protection of data about their health.  Additionally, the law gives individuals the right to 
have access to all of the facts collected concerning their health. The law also protects an 
individual’s rights not to be informed regarding issues pertaining to their health. The law 
can limit these rights for the benefit of a patient but only as an exception. Every individual 
has the right to privacy of personal data, including the data connected with their health 
condition, including for example information gathered for a potential diagnostic 
procedure and treatment, as well as the protection of privacy during diagnostic 
procedures, regarding services by specialists and medical and surgical procedures in 
general. All of the data containing information about the health of an individual, including 
medical and surgical interventions, must be considered private and thus protected. In 
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short, individual privacy must be respected. Medical and surgical procedures (diagnostic 
procedures, examinations by medical specialists, consumption of medications) must be 
organized in suitable fashion and in the presence of those who are supposed to be there 
(only in case when a patient gives his/her explicit consent or has alternative requests). 
The goal of the European Charter on Patients’ Rights,3 and also numerous related 
directives, is to guarantee a high level of the protection of people’s health (Turk, Leyshon, 
Pytte, 2015: 79).  
 
The EU, together with supranational legislation both regard privacy as a fundamental 
requirement under European human rights law. The data protection reform package 
entered into force in May 2016 and will take effect in May 2018. This reform package 
includes the general data protection regulation which updates and modernizes the 
principles enshrined in the 1995 Data Protection Directive4 to guarantee privacy rights. 
The process of implementing some of the main data protection directives under this 
regulation is currently a high priority.5 
 
Concerning Serbia’s legal system, the basic notion of respecting a professional secret 
originates from one of the most important guarantees of the Constitution, namely the 
stipulation regarding the right to respect one’s private life.6 Personal data protection is 
guaranteed. Collecting, storing, processing and using personal data is regulated by law. 
In accordance with law, everyone has the right to be informed about personal data 
collected, and the right to legal protection in the case of abuse or breach of the law. The 
confidentiality of the contents of letters as well as the means of communication is based 
on their inviolability. Deviations from the law are allowed only for a short period of time, 
and with a court decision, for the purpose of criminal procedures and for protecting the 
safety of the Republic of Serbia as prescribed by law. 
 
Storing and dealing with data that are of public but not private importance is regulated 
by The Act on Free Access to Information of Public Importance.7 This law stipulates that 
competent authorities must deny a requestor’s   access to information of public 
importance if there is a risk that disclosure will violate someone’s right to privacy, 
reputation or any other right of a person that the requested information refers to. The 
exceptions to this provision are as follows: 1) if an individual gave his/her consent to 
disclosure; 2) if the requested information pertains to a person or a situation that is of 
some public interest, particularly if it is about a state official or someone with a political 
background; and 3) if the requested information pertains to a person whose behavior was 
the reason for requesting information. 
 
The Criminal Code of Serbia governs situations where there is an abuse or unauthorized 
disclosure of confidential information.8 An unauthorized person, who discloses 
confidential information that he/she discovered while doing their job (lawyers, 
physicians, etc.), will be fined or sentenced to up to one year imprisonment. A person, 
who discloses confidential information that is of general interest or in the interest of some 
other person whose interest in having the information outweighs keeping the information 
confidential, will not be punished. Besides this criminal offence, unauthorized access to 
an encrypted computer, computer network or electronic data processing (EDP) subjects 
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the offender to a fine or up to six months’ imprisonment. The use of downloaded data 
subjects the offender to a fine or up to two years’ imprisonment. If the violation causes 
an interruption or a serious problem in functioning of EDP, data transmission or network 
or there are some serious consequences, an offender will be sentenced to three years’ 
imprisonment (Milošević, 2010: 1–11).  
 
Both the Health Care Act9 (HCA) and the Patients’ Rights Act10 (PRA) apply to regulate 
the medical professions and the staff working in the field of health care systems. These 
regulations ensure that every patient is entitled to the privacy of their personal health care 
information including their medical condition, potential and actual diagnostic procedures 
and all medical treatment. The law strictly forbids medical staff to convey personal 
information about a patient to other persons. A patient can be examined and medical 
treatment rendered only in the presence of medical staff and their associates. A patient 
can, however, give his/her consent to allow the presence of other persons during medical 
examinations and treatment.11 Regulations that refer to medical documentation itself, and 
to the collection of data through the records in the health care system, prescribe that 
managing documentation within the health care system is a part of professional medical 
work, and therefore is given public importance, whereas the field of data protection is not 
regulated in any particular way. In that sense, collection, use and data protection from the 
records in the field of health care system should be in accordance with the law that 
regulates the protection of personal data.12  
 
Currently, the Serbian Parliament is preparing to adopt the Draft on the Pharmaceutical 
Affairs Act.13 This is an important step because the Republic of Serbia previously lacked 
legislation that would regulate this field, with the exception that the HCA contains only 
general provisions. This indeed will be historical legislation, and long awaited since the 
time of the Kingdom of Yugoslavia.14 The new Act outlines the main principles in this 
field and governs documentation management. However, a severe limitation or 
deficiency in the Act is that it does not r the issue of pharmaceutical secrecy or 
confidentiality. Namely, the principle of respecting human rights and values in the 
pharmaceutical field implies the highest possible standard in carrying out pharmaceutical 
business. That is, the right to life, physical and mental integrity as well as the integrity of 
human dignity, respect of moral, cultural, religious and philosophical beliefs of people 
(HCA, Article 4). Managing medical documentation and records in the pharmaceutical 
field is performed in accordance with this law, as well as the law that regulates medical 
documentation and records and refers to medications and medical equipment (HCA, 
Article 4). The law prescribes that a pharmaceutical inspector must act in accordance with 
a duty of care and impartially when carrying out supervision and must maintain data that 
he or she came across during his/her inspection as a professional secret, especially the 
data that refer to medical documentation of a patient (HCA, Article 55).  
 
Legal procedures in Serbia point to the seriousness of possible problems due to the 
unlawful disclosures of professional secrets and breaches of confidentiality and the 
sensitivity of jobs that health care professionals and pharmacists perform. 
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There is a still the need for greater professional behavior by all participants in the health 
care system. Concerning current health care there is a tendency to respect dignity and 
individual rights to a greater extent, where consequently a patient as a consumer of 
different services in medical and pharmaceutical care should also enjoy more specific 
legal protection. But in the same time the Serbian legal authorities show deficit in control 
and processing the cases of confidentiality malpractice. Namely, for a long period there 
has only been a few cases where the courts have awarded damages because of the 
disclosure of the information about HIV status of a female patient (Petrović-Škero, 2004: 
28).15 Besides, court practice is still clearly undeveloped concerning the pharmaceutical 
health care issues.  
 
3 Importance of privacy 
 
Determining privacy of data can be evaluated from both the normative and factual point 
of view. Namely, data privacy implies that protections stem from law, other regulations, 
general act or any other act passed according to the law and thus pronounced confidential: 
documents, contents and attachments, subjects, objects, measures or acts as well as 
official announcements or confidential information presented in the work of state officials 
or other legal entities (McHale, Fox, 2007: 623). Depending on the kind of privacy, data 
can be qualified as a state, military, official, business and professional secret. Depending 
on the level of privacy, data can be qualified as constituting a state secret, classified or 
strictly confidential data. A professional secret, on the other hand, refers to the data 
pertaining to the personal and family life of clients that medical and social workers or 
other officials discover while performing their jobs. The concept of secret data or 
information refers to everything that a professional discovers about an individual in direct 
communication, which should not be made available to others, especially those that could 
endanger him/her (Radišić, 2008: 157). Confidentiality is vitally important in professions 
connected with individuals that have psychological, psycho-pathological or social 
problems. These especially sensitive cases are regulated by special codes mandating strict 
obligations of maintaining professional confidentiality except in rare cases involving 
exceptional reasons or a court order (Mujović Zornić, 2011: 187). 
 
The concept of confidentiality is deeply rooted in the right to privacy, just as the concept 
of the right of privacy is deeply rooted in the notion of the autonomy of an individual 
(Nassar, 2009: 228). Starting from the concept of self-autonomy, it follows that being 
truly autonomous means having the freedom of thoughts and actions without any 
interference or limitations by others. Absolute autonomy is abstract. For example, a 
person cannot act freely in a way that endangers others. No law is necessary to prescribe 
that. Privacy is not one particular ethical principle by itself. To the contrary, it is inter-
connected with a number of principles. The concept of privacy reveals respect for 
autonomy of an individual and his/her right to control personal information. The health 
care professional that learns of a patient’s secret during the course of the professional 
relationship is working for the patient’s benefit, and is working in the patient’s best 
interest. True autonomy insists on the right to a certain level of privacy. It could be best 
described as an absolute and irrevocable right to enjoy and have control over oneself 
(Beauchamp/Childress, 2001: 294–295). Everyone should have the right to keep private 
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the things i.e. information, they do not want others to find out. The obligation of keeping 
a professional secret (that is, maintaining confidentiality) refers to the facts that are 
known only to a limited circle of people. Private or confidential information is that 
information coming from a private sphere of a particular person, which does not have to 
be of paramount importance. Moreover, information that is subject to confidentiality does 
not necessarily have to be the data that can be objectively identified. Instead, the true test 
of confidentiality is whether a patient has a reasonable interest in the privacy of the 
information deserving of legal protection. That prerequisite is met in a situation where, 
for example, the disclosure of those data could endanger a patient in any way or it could 
hurt his/her psychic integrity. It prevents the situations to make wrong, relative, or false 
the criteria used to describe a secret. It means that everyday information are excluded, 
e.g. somebody had a cold or broke his/her leg when skiing. Disclosing such information 
does not interfere with the interest that deserves protection (Radišić, 2008: 158). On the 
other hand, the benefit of maintaining confidentiality is not valued objectively. Instead, 
subjective criteria are used without any legal or moral evaluation as the person the 
information refers to should insist on making it unavailable to the third party. 
 
4 Confidentiality in the health care system 
 
4.1 The obligation of maintaining confidentiality  
 
Health care services employ measures to ensure that healthcare professionals respect the 
privacy interests of every patient by fulfilling their duty to properly maintain the 
information they gather during patient treatment. In the past, when care was somehow 
less complicated, professionals did not think of exchanging data about a patient except 
with other medical experts directly involved in his/her care without previously discussing 
it with a patient. Today, however, medical insurance and public awareness about people’s 
health demand the collection and maintenance of very rigorous records of diseases and 
patients, systematic reporting and informing. Officials working in the field of health 
insurance are obliged to keep the data about a patient confidential. To help ensure the 
confidentiality of patient information encrypted medical diagnoses and reports are often 
used. EDP and medical documentation present serious obstacles for the obligation of 
keeping patient information confidential. Research has shown, for example, that users 
either do not know much or they do not think about how many people have legitimate 
access to what they consider confidential information. The case usually quoted is about 
a patient worried about the number of people who could have access to his medical 
documentation while he was hospitalized. His concern was such that he threatened to 
discontinue treatment. Research revealed that a number of medical staff had a justifiable 
need and responsibility to access and review the patient’s medical chart. In fact, the chart 
was accessed 75 times (Nassar, 2000: 226). In practice, this implies that personal 
information presented to other medical professionals or the one officially acquired during 
the treatment, in its essence, stay confidential. For example, medical information 
presented to a clinical physician in order to prescribe a tranquilizer is personal 
information and it would be reasonable to expect of a physician to keep it confidential. 
That is why a legal platform was adopted requiring that medical professionals and even 
pharmacists should start from the premise that a patient is not willing to have his/her 
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personal information disclosed but that in a specific case this premise can become a 
rebuttable presumption based on the patient’s statements or actions.  
 
The patient has absolute autonomy over the own health’s information and his/her decision 
is based on the physician - patient relation that has been developing for centuries. Neither 
medical professionals nor pharmacists should forget that the patient’s autonomy is a 
matter of trust. 
 
4.2 Specificities of a pharmaceutical profession 
 
Patients expect pharmacists to be competent in terms of their compliance with 
professional standards and with the standards of duty of care adopted in pharmaceutical 
practice. These expectations are present as well when it comes to the issue of the 
protection of privacy. Generally speaking, in this sphere, legal issues and professional 
ethics overlap. Very often, professional organizations like chambers are asked for help. 
The Pharmaceutical Chamber of Serbia passed the Ethical Code of Pharmacists in 2006.  
Principle no. 4 is the rule governing professional secrecy at work.16 A decree has been 
enacted according to which a pharmacist should keep all  information  about an individual 
that he/she gathered during work confidential, as that information is considered by law a 
professional secret. The law mandates that in addition to personal information about an 
individual, a professional secret of medical workers includes the following: the history 
of the disease, lab results, prescribed medications as well as medical equipment. 
 
The obligation of maintaining confidentiality extends not only to pharmacists but also to 
all employees working in a pharmacy, including also anyone who encounters any 
confidential information while performing their job. A pharmacist has a moral obligation 
to minimize the risk of unauthorized and unnecessary access to confidential information 
(computer data encoding, etc.). A responsible pharmacist in any health care institution 
(hospital, clinic and/or pharmacy) is supposed to take steps to ensure that anyone who 
has access to confidential information should be aware of the importance of respecting it. 
Confidential information may be disclosed only in strictly specified cases. In order to 
prevent serious consequences or endangering a patient’s health, the health of a third party 
or the public health in general, the amount of information disclosed and the number of 
those it is disclosed to should be limited to the maximum extent possible. A pharmacist 
should also make sure that services rendered to adolescents should not be disclosed to 
their parents given the legitimate concern about building and maintaining trust between 
a pharmacist and an adolescent. Information about a physician’s habit of prescribing 
some medications or physician’s work in the sense of his experience or knowledge is also 
considered confidential. For that reason, a pharmacist is obliged to respect the physician’s 
right to confidentiality even in that sense. Other pharmaceutical codes, when examining 
the comparative law, mostly refer to the work of pharmacists in a pharmacy setting, and 
indicate that pharmacists are obliged to: 1) respect a contractual relationship between a 
patient and a pharmacist, 2) promote welfare of each patient in an attentive, conscientious 
way full of trust, 3) respect autonomy and dignity of each patient.17  
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Understanding the importance of legal terms (autonomy, privacy and confidentiality) in 
specific working environment could be at stake due to the dynamics of the health care 
system. For example, a pharmacist involved in the treatment of a patient with 
contagious/infectious diseases faces situations where rights are treated differently from 
those when they treat patients in some other wards. There are also legal requirements to 
record certain information about contagious/infectious diseases that are not obvious. A 
pharmacist involved in the long-lasting treatment and care of less capable patients, for 
example, who can hardly be seen in most health care institutions, is in a position to co-
operate with other staff members depending on the medical institution he/she works in. 
With his/her personal involvement in the protection of the patient’s right to autonomy, 
privacy and confidentiality, a pharmacist can be an example to other medical professions 
and associates responsible in their mutual care for a patient.  
 
Sometimes the health care institutions are engaged in the practice of communicating with 
family members about a patient’s care, especially with a spouse, although a patient did 
not previously show any personal interest in it. The reasons for that could be find in 
therapeutic excuse, which is in the best interest of the patient. Besides, information about 
a patient undergoing lengthier treatment is regularly shared with other members of the 
medical team, regardless of their need to know it. Pharmacists are asked to apply Good 
Pharmacy Practice and form their own approach with an aim to protect the patient’s 
privacy when it comes to delivery of medications. For example, in many clinical 
procedures it is noticeable that information about a patient does not correlate with 
physician’s duties in order to protect personal data. Also the most pharmacists-
consultants can confirm the fact that information about patients with institutional and 
long-lasting care is often easily accessible, even to the public. That kind of practice should 
not be tolerated. Focusing attention on these shortcomings is just one of the examples of 
how a conscientious and careful pharmacist can influence his/her working environment 
with an effect to respect and protect the patient’s basic rights. 
 
The law of confidentiality has developed through case law and is supported by various 
statutes. Practice in question points out as well to the situations in developed countries 
where health insurance companies disclose information about the number of patients with 
certain diagnoses or some pharmaceutical companies pay directly to pharmacies in order 
to obtain access to patients’ personal data. Comparative practice shows, for example, 
some similar cases: 1) A patient was convinced that the information about psoriasis 
treatment he had shared with a pharmacist and a physician was confidential because, a 
few months later, he started getting internet messages about the same treatments;18 2) The 
Supreme Court of the USA decided in favor of privacy when prescribing medications and 
their consumption and also in favor of the integrity of the physician - patient relation. 
According to this decision it is unacceptable for pharmacists to give information about 
which physician prescribes which medications and to which patients judging by gender 
or age;19 3) A patient at a high-security psychiatric hospital who was suffering from 
mental illness was not entitled, under the Data Protection Act 1998, to full disclosure by 
an NHS trust of a psychology report or disclosure only to his legal representatives. There 
were clear and compelling reasons based on cogent evidence to support the decision not 
to disclose, and no injustice had been caused as the patient had had a fair opportunity of 
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presenting his own psychological evidence. The court rejected both grounds of the 
application. It was also held that R would suffer no injustice from the non-disclosure. 
While Article 6 required that R receive a fair trial, this did not give him an absolute or 
unqualified right to see every document. In any event, as the Trust was not obliged to 
provide a report, the MHRT did not have any power to compel disclosure.20 
 
4.3 Release from obligation of maintaining confidentiality  
 
The right to privacy and confidentiality does not necessarily imply an absolute right. To 
the contrary, there are certain exceptions to the idea of complete confidentiality, which is 
confirmed in both medical and judicial practice. Medical confidentiality arises from both 
the nature of the information concerned and the fiduciary character of the pharmacist - 
patient relationship. There has been a movement towards greater patient, as opposed to 
professional, control of health information. Decisions about disclosing information 
should be made on a case-by-case basis and only after fully considering all relevant 
factors. Disclosure can be made in several forms: disclosing information with consent; 
disclosing information without consent; disclosures required by law; and, disclosures 
made in the public interest.  
 
Legal literature quotes an example of where a psychotherapist made a mistake because 
he kept information about a patient as a secret that he was obliged to disclose (Nassar, 
2000: 230). In the case in question, a patient with a mental disorder told his psychiatrist 
that he was intending to kill his ex-girlfriend. The psychiatrist found out the girl’s name 
and he had the possibility of warning her or reporting those threats to the police but he 
failed to do so. The tragedy happened as the patient had carried out his threats and killed 
his girlfriend. The court pronounced the psychiatrist liable since he failed to take any 
steps to warn the victim. The court explained that the protection of the relation based on 
trust is favored only until it is necessary, but not when disclosure of information becomes 
of greater importance in order to protect other people who are in danger. In other words, 
the privilege has limits, and the privilege of privacy ends where there is general, public 
interest that requires disclosure of otherwise confidential information in order to prevent 
or eliminate danger to the larger public. It is more than obvious that the psychiatrist 
should find a moral and legally based logical reasons for it. Similar to that, many laws 
contain jus cogent/peremptory provisions norms insisting on reporting, like in the 
situations of contagious/infectious diseases or with at least some suspicion of abuse. The 
same are in general legal norms which clearly focus on the protection of corporal or 
mental integrity of other people from criminal acts. 
 
According to the opinion of the majority of lawyers, the term of unauthorized disclosure 
of a secret should be equated to the term of unjustifiable i.e., unlawful disclosure. 
Exceptions to unlawfulness are strictly prescribe by law (requests by the court or any 
other body or jus cogent/peremptory norms e.g. the norms about mandatory reporting and 
registration of certain diseases), or they stem from general circumstances that exclude 
unlawfulness as follows:  consent of an authorized person; implied consent of an 
authorized person; the state of absolute necessity;  the defense of his/her justifiable 
interests (Radišić, 2008: 160-4). The patient’s consent is the reason that releases him/her 
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from maintaining confidentiality and it stems from the patient’s right to self-
determination, which is of paramount importance. Consent from the patient’s statement, 
or the statement of his/her legal representative (a parent, a guardian, an adoptive parent), 
that he/she does not want something to be a secret any more. Third persons are not 
authorized to give that kind of consent, not even in the case when they personally 
communicated the secret about a patient to a medical professional. However, if the secret 
refers to a third person, his/her consent is also necessary; the statement of will, which 
means consent, can be given in any form, expressed by words or conclusive acts. Implied 
consent is considered to be the reason for release from keeping a secret and it is not just 
a sub-type of the state of necessity. Implied consent is important in cases when a patient 
is not capable of giving his/her consent (because he/she died, lost consciousness or is 
mentally ill) or we can conclude from certain circumstances that a patient has no interest 
to keep a secret. The contents of implied consent can be assumed from a patient’s personal 
circumstances, interests, wishes, needs and attitudes that imply the standard of a 
reasonable patient (Radišić, 2008: 162). If there is no firm ground to believe that a patient 
would object to it, there is always a state of absolute necessity when, because of general 
interests, either public or private, the only way to avoid danger is to reveal a secret. 
 
The foregoing explains why an example of contagious/infectious diseases is taken when 
the law allows a medical worker to communicate the information about a patient’s health 
condition to a major member of his/her family, in cases when it is necessary in order to 
avoid health risks for a family member. The right to reveal a professional secret can be, 
under certain circumstances, reversed into an obligation of disclosing a secret.21  
 
4.4 Breach of confidentiality 
 
Threats to confidentiality i.e., protection of classified information can be found in the 
whole health care system. On the one hand, electronic information has become more 
wide-spread. On the other hand, it has become rather difficult to limit access based on the 
criterion of necessity, i.e., authority to have information about some data. Thus, if a 
company is asked to organize with corporate physicians regular medical check-ups for its 
employees, documents are computerized and connected with other browsers. Most 
employees suspect that, in that way, copious documentation found in two places, and the 
part connected with medications, can be used against them. Employees also point out 
that, in cases like this, a physician has a greater interest to disclose confidential 
information to the company as an employer than to respect the patient’s right to privacy. 
For example, a patient is in charge of some work that demands critical attention and full 
concentration and the absence of which can cause damage to him/her as well as to the 
others. A physician, who finds out that a patient is taking antidepressants, which affect 
cognitive functions, should not in these circumstances give priority to the patient’s right 
to privacy. Instead, here the priority should be given to the society in order to protect the 
public good and welfare. However, a definite solution may be in better protection of 
employees who could also be the subject to an inspection at their private, elected 
physician as a counselor in this matter. The elected physician takes in account patient’s 
interests and could make a better balance weather to tell or not to tell employer some 
sensitive health information. 
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There is a difference between a violation of confidentiality and breach of privacy rights, 
at least in the sense these issues are considered here (Nassar, 2000: 228). As previously 
stated, confidential information is the one given freely or collected by professionals 
during the treatment. If a patient previously gives his/her consent that that information 
can be communicated to others (a spouse, an employer, an insurer, etc.), there is no 
violation of confidentiality that is owed to him/her. A violation is obvious only in cases 
when information about a patient or his/her treatment is given to those who have no 
authority to get it and there was no good reason to justify that violation of primary health 
care. A violation of confidentiality supposes that it is performed by those who are 
authorized to have that information. It is quite different if a person who violates this right 
is not authorized. If an unauthorized person comes into possession of the information (in 
a specific situation or any other way), then we can talk about breach of privacy and 
unauthorized dissemination of information, which is totally unacceptable and thus 
punishable. This breach can be done by any other person employed in a medical 
institution. Any ethical discussion would emphasize the importance of confidentiality and 
the right to privacy should be protected. Trust is an important condition of civilized 
behavior so the health care service could hardly work well without it. When there are 
duty-based ethics either towards an individual or a group and they become really crucial, 
it gets its legal form in legal acts provisions. Since there is no particular provision 
regarding trust that develops between a physician and a patient, data protection is derived 
from administrative and general legal solutions: 1) priority given to confidentiality in the 
communication with a patient means introduction of encrypting official records by means 
of codes; 2) tort law protects information privacy through court proceedings for the 
compensation in case of the damage caused by unauthorized disclosure of a patient’s 
secret. Civil and legal protection is widely accepted as a means of clarifying a dispute 
that involves a clearer explanation of information privacy. An issue of confidentiality in 
a dispute is always a very concrete question where it is necessary to identify if the 
information acquired can be freely shared with others or it is reasonable to consider it 
classified and protected. 
 
There is a lot of discussion in the pharmaceutical business concerning the parameters of 
when information about a patient may be disclosed and disseminated (Nassar, 2000: 229). 
In all areas of their practical work, there is a rule for pharmacists providing that, since 
they have learned about a patient’s diagnosis, they are allowed only to give information 
which is necessary and relevant for the patient’s treatment, but nothing more than that. 
Also, legal issues may be raised concerning how best to handle electronic transmission 
of medical data with an aim of the protection of patient’s privacy. Privacy and safety of 
the data of this kind of confidentiality is taken into consideration in comparison to the 
data gathered through public health care system data processing. Many are of the opinion 
that all the data, which are considered sensitive for a patient, should be sent to health care 
agencies in order to provide continuity of the treatment. Take for example, a potential 
treatment of a patient with multiple resistance to TB medications. Each patient from this 
group is firstly monitored as someone who can be cared for in different facilities, 
including an emergency department, a clinic for an HIV treatment, homeless shelters, 
even prisons. Patients with the highest level of risk may be the ones with the least 
probability of coming back and asking for help or even for the treatment that suits them 
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better. Continuity of treatment and care can be improved if there is a possibility for 
institutions to share sensitive information about a patient. With an idea that health care 
will improve if information is shared, one of the suggestions is, also, to adopt common 
standards of protection regarding privacy and data safeguards. In the other words, all 
information users (receivers) are expected to have the same standard of requests for 
privacy and safety just as the initiator of information does. Some state agencies, for 
example, may have a developed electronic system for the protection and keeping sensitive 
information about a patient but they gladly share it with other agencies with an aim of 
providing patients with better medical care. The agency that receives information has a 
legal obligation to protect and keep it the way that is equal to or more developed than the 
sender’s. This rule, wherever it is adopted as an official standard, refers to pharmacists 
as well. In practice, it means that, if a clinical pharmacist or the one working in the 
production, comes across some data about a patient, who uses a certain medication, 
should provide the same level of protection provided to patients in authorized pharmacies. 
The issue of privacy regarding medical records refers to the each part of health legislation 
and includes different levels of care. Team work in the health care system, especially in 
long-lasting and institutional care, is a proper way of managing a limited budget and its 
allocation in order to reduce medical costs. Necessary as it is, team work enables access 
to medical information to a greater extent than it can be found in some other forms of 
care and treatment. Actually, it is fundamental to make sure that all team members, and 
staff members who are in direct contact with a patient, understand the importance of 
patient’s privacy, what is implied by it and their obligation to protect it respecting 
patient’s individuality. 
 
Concerning the European court practice the protection of medical data falls under the 
scope of Article 8 of the European Convention on Human Rights (ECHR).  
 
In the case Elberte v. Latvia the European Court of human rights held that there had been 
a violation of Article 2 (right to life) and of Article 8 (right to confidentiality) for personal 
information concerning health which had been sent to a German pharmaceutical 
company. Following the death of the applicant’s husband in a car accident, tissue was 
removed from his body during an autopsy at a forensic center and sent to a pharmaceutical 
company in Germany with a view to creating bio-implants, pursuant to a State-approved 
agreement. The domestic authorities’ failure to secure the legal and practical conditions 
to enable the applicant to express her wishes concerning the removal of her deceased 
husband’s tissue constituted an interference with her right to respect for private life. 
 
In the case of Mr and Mrs Campbell22 the Court stated that there was no indication that 
Mrs. Campbell’s life expectancy had been reduced by the decision of the health authority. 
What is clear, however, is that the new drug was effective in Mrs. Campbell’s case and 
had improved her quality of life. In this type of situation, arguments based upon Article 
8 may be appropriate (right to respect for private and family life). The decision of the 
health authority in restricting the prescribing of the drug with the result that some people 
in the area are being prescribed it, and others are not, could be held to be discriminatory 
if there is no objective reason for the policy, and so Article 14 could also be engaged. In 
174 LEXONOMICA 
H. Mujovic: Medical-Legal Aspects of Confidentiality in the Field of Pharmaceutical 
Health 
 
the postcode prescribing type of situation, the courts would be more likely to find in a 
patient’s favor, if there was evidence that the restricted medication would be. 
 
One of the cases is Wretlund v. Sweden decision23 where the applicant complained that 
her obligation to undergo drug testing, as laid down in the Labour Court judgment, 
interfered with her right to respect  her private life under Article 8.1 of the European 
Convention. She claimed that there was no Swedish legislation giving employers the right 
to conduct drug tests on their employees and that, consequently, the Labour Court's 
judgment had no basis in law. Thus, the interference in the case was not 'in accordance 
with the law' as required by Article 8.2 of the Convention. Further, even assuming that 
the interference was lawful, she argued that the compulsory drug test could not be 
considered a justifiable measure having regard to her duties as an office cleaner. The 
ECHR thus found that the measure challenged by the applicant had a sufficient basis in 
Swedish law and thus was 'in accordance with the law' within the meaning of Article 8.2. 
The ECHR also concluded that the operation of a nuclear power plant obviously required 
a very high level of security and that it was necessary to apply various procedures, 
including control measures. It was evident to the Court that the use of drugs among the 
employees might jeopardise the security at such a plant. A drug policy programme 
involving regular drug testing of staff must be considered as justified. 
 
Court practice notes that all members of healthcare staff are bound by a duty of 
confidentiality. In 2010, the European Court of Human Rights decided the case I v. 
Finland.24 Ms. I was a nurse at a hospital in Helsinki who was HIV positive. The systems 
at the hospital enabled every clinician to see every patient’s notes, and in consequence 
her colleagues discovered her HIV status, and hounded her out of her job. She sued for 
compensation, and the ECHR found that Finland had breached her right to privacy by 
failing to provide an environment in which she could keep her medical information 
confidential: What is required in this connection is practical and effective protection to 
exclude any possibility of unauthorized access occurring in the first place.  
 
5 Conclusion 
 
It is essential that pharmacists take steps to protect the confidential information they are 
given either in the course of their professional practice or because they are a pharmacy 
professional. As the concept of pharmaceutical care is getting more grounded, there are 
an increasing number of situations when pharmacists are obliged to collect patients’ data, 
not only to dispense medications, but also because they have to deal with some very 
sensitive pieces of information. It is often a very serious problem for them.  
 
The concept of professional secrecy, as any other form of discretion regarding different 
professions, is widely conceived. The duty of confidentiality applies to information about 
any person, whatever their age, and continues to apply after a person’s death. The scope 
of protection is not solely determined by legislation, e.g. legal standards regarding 
rendering professional services, but also the idea to reach the level of individual rights of 
every person in general. There are no clear laws or professional rules in pharmaceutical 
practice to direct them in this field. Consequently, the private sphere of the patient is 
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increasingly endangered. It cannot be said in advance that something is in the scope of 
privacy because it often depends on the specific case, its circumstances, its sides and 
relations, both in factual and legal sense. 
 
The duty of keeping the secret is undermined by the general social progress and progress 
of medical activity, which makes health insurance more massive and the distribution of 
work in medicine is more complete, the private sphere of the patient is increasingly 
endangered. The two-way relationship between a pharmacist and patient is sometimes 
transformed into a multiple-party relationship, and the duty of keeping professional 
secrets is significantly relativized. Compulsory health insurance has transformed the two-
way relationship with the patient into a three-way relationship. This is the same reason 
why the obligation of professional secrecy in the area of pharmaceutical health care has 
been significantly re-evaluated as well. Namely, health insurance and public health care 
require rigorous records of illness and patients through systematic reporting and 
disclosure. The health and social security providers also have the obligation to keep the 
information on the patient secret and often use the so-called digitized diagnoses and 
reports. In the long run, electronic data processing and medical documentation make more 
risk to professional secrecy obligation. The health care system and in this regard aspects 
of pharmacy care can put a private sphere of the patient at a greater risk. In this situation 
the obligation of professional secrecy could become quite indefinite.  
 
Regarding the above issues, the development of law as a system is a necessity. Thus, the 
development and implementation of human rights’ standards should always be a 
continuous process that improves over time and has its own tradition in the field of 
privacy. Endangered in many ways, the obligation of secrecy, however, is somewhat 
maintained and lasts. 
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Notes 
 
1 Convention for the Protection of Human Rights and Fundamental Freedoms (1950). Serbia 
ratified it in December 2003 with legal effect since March 2004. Article 8. Official Gazette of 
Serbia and Montenegro International agreements. 2003: 9 and 2005: 5. 
2 Convention on Human Rights and Biomedicine Oviedo (1997) Article 10. Serbia ratified it in 
December 2010; Council of Europe Convention for the Protection of Human Rights and Dignity 
of the Human Being with Regard to Biology and Medicine: Convention on Human Rights and 
Biomedicine, Oviedo, 4 April 1997, in force 1 December 1999, ETS No. 164, 
http://conventions.coe.int/ treaty/en/treaties/html/164.htm Signed in the moment of adoption by 17 
states: Denmark, Estonia, Finland, France, Greece, Italy, Latvia, Lithuania, Luxemburg, Holland, 
Norway, Portugal, Romania, San Marino, Slovakia, Slovenia and Spain, and later by 18 states more 
(Turkey. Switzerland, Serbia, Moldova, Montenegro, Albania, Bosnia and Herzegovina, Bulgaria, 
Croatia, Cyprus, Czech Republic, Georgia, Hungary, Iceland, Poland, Sweden, Macedonia and 
Ukraine). 
3 European Charter on patient' s rights, Roma (2002), available at: ec.europa.eu/health/archive 
/ph.../ co.../health services co108_en (March 19, 2017)   
4 Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the 
protection of individuals with regard to the processing of personal data and on the free movement 
of such data (OJ L 281, 23. 11. 1995, p. 31. 
5 Council of Europe Data Protection Convention (1981); Directive 2011/24/EU of the European 
Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border 
healthcare (OJ L 88, 4.4.2011, p. 45); Directive (EU) 2016/680 of the European Parliament and of 
the Council of 27 April 2016 on the protection of natural persons with regard to the processing of 
personal data by competent authorities for the purposes of the prevention, investigation, detection 
or prosecution of criminal offences or the execution of criminal penalties, and on the free movement 
of such data, and repealing Council Framework Decision 2008/977/JHA 
6 Constitution of the Republic of Serbia (2006) Official Gazette of the Republic of Serbia, 83, 
articles 41-42 
7 Article 14, The Act on Free Access to Information of Public Importance, Official Gazette of the 
Republic of Serbia, No.120/2004, 54/2007, 104/2009 and 36/2010 
8 Article 141 and Article 302 Criminal Code of the Republic of Serbia, Official Gazette of the 
Republic of Serbia,85/2005 am. 72/111/2009 
9 The Health Care Act, Official Gazette of the Republic of Serbia, 107/2005…93/2014, 96/2015 
and 106/2015 
10 Patient Rights Act, Official Gazette of the Republic of Serbia, 45/2013 
11 Article 30, ibid. 
12 Article 3, The Act on Health Records and evidence in the Field of Health Care, Official Gazette 
of the Republic of Serbia,123/2014, Article 7. See also: The Medicines and Medical Devices Act, 
Official Gazette of the Republic of Serbia, 107/2012, Article 31 and Article 137.  
13 Available at: 
http://www.zdravlje.gov.rs/downloads/2017/Januar/Nacrt_zakona_o_apotekarskoj_delatnosti.pdf 
and http://www.parlament.gov.rs/akti/zakoni-u-proceduri/zakoni-u-proceduri.1037.html 
(November 25, 2017). 
14 Zakon o apotekama i nadzoru nad prometom lekova (1930) ZBIRKA zakona, uredbi, pravilnika 
i propisa o apotekama sa izvodima iz ostalih zakona, koji su u vezi sa apotekarskim radom i 
pozivom, Apotekarska komora Kraljevine Jugoslavije, Beograd. pp. 6-240. 
15 District court in Požarevac Gz. 83/1996; verdict based on the reversed decision of the Supreme 
Court of the Republic of Serbia, REV.392/2003. 
16 Ethical Code of Pharmacists of Serbia, Official Gazette of the Republic of Serbia, 6/2007 
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17 A good example sets Ethical Code of Pharmacists adopted by ASCP in 1992, Nassar, quotation 
described, available at: www.asqh.org/threads/ (January 28, 2017)   
18 Available at: www.nepanet.wordpress.com/2011/02/03/ (April 11, 2017).   
19 Decision from March 2011. Since 2003 in USA, there have been new laws that created to prevent 
illegal disclosure of Confidential Patient Information, known as the HIPPA Act; Available at: 
http://www.resource4 pharmacy malpractice.com/disclosure.html (November 25, 2017). 
20 Roberts v Nottinghamshire Healthcare NHS Trust [2008] EWHC 1934 (QB). 
21 Article 37, paragraph 6 The Health Care Act, op.cit.  
22 Chaos over funds for Alzheimer’s drugs’, BBC News on line, 11 October 2000. 
23 Wretlund v. Sweden decision The European Court of Human Right (ECHR) application 
no.46210/99. 
24 I v. Finland ECHR Application no. 20511/03. 
 Note: this topic was discussed as well as a result of the project No.179023 supported by the 
Ministry of Science of the Republic of Serbia, realized by the Center for Legal Research of the 
Institute of Social Sciences in Belgrade 
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